STOCK TITAN
  1. Home
  2. Sec-filings
  3. MGTX
  4. [144] MeiraGTx Holdings plc SEC Filing

[144] MeiraGTx Holdings plc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock MGTX logo
Meiragtx Holdings Plc

NASDAQ:MGTX

MGTX Rankings

#4101 Ranked by Market Cap
N/A Ranked by Dividends

MGTX Latest News

May 13, 2025
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
May 13, 2025
MeiraGTx Reports First Quarter 2025 Financial and Operational Results
May 9, 2025
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease
Mar 13, 2025
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
Mar 13, 2025
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process

MGTX Latest SEC Filings

Jul 22, 2025
[Form 4] MeiraGTx Holdings plc Insider Trading Activity
Jul 8, 2025
[Form 4] MeiraGTx Holdings plc Insider Trading Activity
Jul 8, 2025
[144] MeiraGTx Holdings plc SEC Filing
Jul 2, 2025
[Form 4] MeiraGTx Holdings plc Insider Trading Activity
Jun 26, 2025
[8-K] MeiraGTx Holdings plc Reports Material Event

MGTX Stock Data

688.73M
48.16M
39.24%
58.91%
2.53%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW YORK